Randomized Study Comparing Tamoxifen vs. Tamoxifen + Aminoglutethimide in Postmenopausal Receptor-positive Patients
Status:
Completed
Trial end date:
2000-03-01
Target enrollment:
Participant gender:
Summary
Primarily, this clinical investigation compared the efficacy of tamoxifen + aminoglutethimide
vs. tamoxifen alone in terms of prognosis (overall survival) in postmenopausal patients with
potentially curative, operated hormone receptor-positive breast cancer.